Suchergebnisse - "Vaduganathan, Muthiah"

PubPharm (10)

1

Sodium Glucose Co-Transporter 2 Inhibition Following Acute Myocardial Infarction : The DAPA-MI and EMPACT-MI Trials

enthalten in: JACC. Heart failure | 2024

von Peikert, A. | Vaduganathan, M.

2

Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection Fraction

enthalten in: JAMA cardiology | 2024

von McDowell, K. | Kondo, T. | Talebi, A. | +17

3

Cost Effectiveness of Dapagliflozin for Heart Failure Across the Spectrum of Ejection Fraction : An Economic Evaluation Based on Pooled, Individual Participant Data From the DELIVER and DAPA-HF Trials

enthalten in: Journal of the American Heart Association | 2024

von Bhatt, A. | Vaduganathan, M. | Claggett, B. | +13

4

Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction : A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial

enthalten in: JAMA cardiology | 2024

von Mc Causland, F. | Claggett, B. | Vaduganathan, M. | +19

5

Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes : an observational cohort study

enthalten in: European heart journal | 2023

von Fu, E. | Patorno, E. | Everett, B. | +5

CommentIn: Eur Heart J. 2023 Jun 25;44(24):2231-2233. - PMID 37287082

6

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

enthalten in: The New England journal of medicine | 2022

von Solomon, S. | McMurray, J. | Claggett, B. | +140

CommentIn: N Engl J Med. 2022 Sep 22;387(12):1138-1140. - PMID 36027566

7

Effects of empagliflozin on insulin initiation or intensification in patients with type 2 diabetes and cardiovascular disease : Findings from the EMPA-REG OUTCOME trial

enthalten in: Diabetes, obesity & metabolism | 2021

von Vaduganathan, M. | Inzucchi, S. | Sattar, N. | +9

8

Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation

enthalten in: Journal of the American College of Cardiology | 2021

von Rangaswami, J. | Lo, K. | Vaduganathan, M. | +1

9

Glucagon-Like Peptide 1 Receptor Agonists and Heart Failure : The Need for Further Evidence Generation and Practice Guidelines Optimization

enthalten in: Circulation | 2020

von Khan, M. | Fonarow, G. | McGuire, D. | +9

10

SGLT-2 inhibitors in heart failure : a new therapeutic avenue

enthalten in: Nature medicine | 2019

von Vaduganathan, M. | Butler, J.

1
[1]